IPG Investment Advisors LLC bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,107 shares of the semiconductor company’s stock, valued at approximately $520,000.
Several other institutional investors also recently modified their holdings of the stock. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Synopsys in the 4th quarter valued at approximately $28,000. Oakworth Capital Inc. grew its holdings in Synopsys by 3,700.0% during the fourth quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock valued at $36,000 after purchasing an additional 74 shares during the period. KERR FINANCIAL PLANNING Corp bought a new stake in Synopsys in the third quarter valued at approximately $38,000. N.E.W. Advisory Services LLC increased its stake in Synopsys by 128.6% in the fourth quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company’s stock valued at $38,000 after purchasing an additional 45 shares in the last quarter. Finally, WealthCollab LLC raised its holdings in Synopsys by 110.8% in the third quarter. WealthCollab LLC now owns 78 shares of the semiconductor company’s stock worth $38,000 after purchasing an additional 41 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Stock Down 8.6%
Synopsys stock opened at $480.64 on Friday. The company has a 50 day moving average of $458.59 and a 200-day moving average of $454.30. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73. The stock has a market capitalization of $92.07 billion, a PE ratio of 111.26, a price-to-earnings-growth ratio of 4.31 and a beta of 1.25.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on the stock. Rosenblatt Securities lifted their price target on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research report on Tuesday. Morgan Stanley raised their price objective on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday. Bank of America lifted their target price on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday. Stifel Nicolaus boosted their target price on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday. Finally, KeyCorp restated an “overweight” rating on shares of Synopsys in a report on Thursday. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $563.81.
More Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys reported fiscal Q2 adjusted EPS of $3.35, beating estimates, on revenue of $2.28 billion, also ahead of expectations, with revenue up 41.9% year over year.
- Positive Sentiment: The company lifted full-year FY2026 guidance, signaling continued demand for AI chip design software and stronger-than-expected momentum across the business.
- Positive Sentiment: Synopsys reached a governance agreement with Elliott Investment Management and added Jesse Cohn to the board, which investors may view as a step toward better capital allocation and execution.
- Positive Sentiment: Several analysts raised price targets after the earnings release, reflecting confidence in the company’s longer-term AI and semiconductor design opportunity.
- Neutral Sentiment: Synopsys also showcased new AI-powered design flows and IP support for Samsung Foundry processes, reinforcing its position in advanced chip design.
- Negative Sentiment: The stock is reacting negatively because investors may be worried that strong results are not enough to offset near-term business mix issues, including softness in chip IP and integration complexity tied to Ansys.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
